Article
New RNAi strategy for selective suppression of a mutant allele in polyglutamine disease.
Oligonucleotides - 1 Dec 2005
Kubodera Takayuki, Yokota Takanori, Ishikawa Kinya, Mizusawa Hidehiro
Abstract excerpt
In gene therapy of dominantly inherited diseases with small interfering RNA (siRNA), mutant allele specific suppression may be necessary for diseases in which the defective gene normally has an important role. It is difficult, however, to design a mutant allele-specific siRNA for trinucleotide repeat diseases in which the difference of sequences is only repeat length. To overcome this problem, we use a new RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
